Human IFN-alpha/beta R1, C-His (ECD) Protein

Usd: 159

Specification

20μg

50μg

100μg

Bulk Order Quote | Customization Request

Catalog# HA210626

Human IFN-alpha/beta R1, C-His (ECD) Protein

Product Information

Product name

Human IFN-alpha/beta R1, C-His (ECD) Protein

Catalog No.

HA210626

Predicted molecular mass

48.5 kD

Protein construction description

A DNA sequence encoding the human IFN-alpha/beta R1 protein (P17181) (Lys 28-Lys 436) was expressed with a His tag at the C-terminus.

Accession

P17181

Protein construction

IFN-alpha/beta R1 (28-436) His

Source

HEK293

Bio Activity

Testing in progress.

Purity

>95% as determined by SDS-PAGE.

Endotoxin

Less than 1.0 EU per μg by the LAL method.

Formulation

Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4, 5% Trehalose, 5% mannitol.

Species

Human

Background

Together with IFNAR2, forms the heterodimeric receptor for type I interferons (including interferons alpha, beta, epsilon, omega and kappa). Type I interferon binding activates the JAK-STAT signaling cascade, resulting in transcriptional activation or repression of interferon-regulated genes that encode the effectors of the interferon response. Mechanistically, type I interferon-binding brings the IFNAR1 and IFNAR2 subunits into close proximity with one another, driving their associated Janus kinases (JAKs) (TYK2 bound to IFNAR1 and JAK1 bound to IFNAR2) to cross-phosphorylate one another. The activated kinases phosphorylate specific tyrosine residues on the intracellular domains of IFNAR1 and IFNAR2, forming docking sites for the STAT transcription factors. STAT proteins are then phosphorylated by the JAKs, promoting their translocation into the nucleus to regulate expression of interferon-regulated genes. Can also act independently of IFNAR2: form an active IFNB1 receptor by itself and activate a signaling cascade that does not involve activation of the JAK-STAT pathway.

Usage guide

Shipping

In general, recombinant proteins are provided as lyophilized powder which are shipped with blue ice. Bulk packages of recombinant proteins are provided as frozen liquid which are shipped with dry ice.

Storage

Please avoid repeated freeze-thaw cycles. Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃ It is recommended that aliquot the reconstituted solution to minimize freeze-thaw cycles.

Reconstitution

Reconstitute at 250 μg/ml in sterile water.

Human IFN-alpha/beta R1, C-His (ECD) Protein

Usd: 159

Specification

Product Information

Product name

Catalog No.

Predicted molecular mass

Protein construction description

Accession

Protein construction

Source

Bio Activity

Purity

Endotoxin

Formulation

Species

Background

Usage guide

Shipping

Storage

Reconstitution

Products with the same target and pathway

Human IL1RL1/DER4/ST2, C-His (ECD) Protein

Application:

Reactivity: Human

Conjugate:

Human IL-5, C-His Tag Protein

Application:

Reactivity: Human

Conjugate:

Human FGF10, C-Flag Protein

Application:

Reactivity: Human

Conjugate:

Human IL-9, C-Flag Tag Protein

Application:

Reactivity: Human

Conjugate:

Human PRDM1, N-Twin Strep, C-His, Flag Tag Protein

Application:

Reactivity: Human

Conjugate:

Human IL-6, Tag Free Protein

Application:

Reactivity: Human

Conjugate:

Human CCL17/TARC, Tag Free Protein

Application:

Reactivity: Human

Conjugate:

Human TRAIL/TNFSF10, C-His Tag Protein

Application:

Reactivity: Human

Conjugate:

Human CD48, C-His Tag Protein

Application:

Reactivity: Human

Conjugate:

Human IL-22, C-His, Flag Tag Protein

Application:

Reactivity: Human

Conjugate:

Human SCF/KITLG, C-His Tag (ECD) Protein

Application:

Reactivity: Human

Conjugate:

Human VEGF-C, C-His, Flag Tag Protein

Application:

Reactivity: Human

Conjugate:

Human CCL3/MIP-1, Tag Free Protein

Application:

Reactivity: Human

Conjugate:

Human TNF RI/TNFRSF1A, Tag Free (ECD) Protein

Application:

Reactivity: Human

Conjugate:

Human CXCL10, C-Flag Tag Protein

Application: